Last quarter (Q ), International Stem Cell's total revenue was $1.70M, a decrease of -7.55% from the same quarter last year. In Q, International Stem Cell's net income was $-343.00K. See International Stem Cell’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 7.59M	$ 7.18M	$ 7.13M	$ 9.47M	$ 11.09M	$ 7.46M
Cost of Revenue	$ 2.87M	$ 2.94M	$ 2.78M	$ 3.93M	$ 4.07M	$ 2.12M
Gross Profit	$ 4.72M	$ 4.24M	$ 4.35M	$ 5.54M	$ 7.02M	$ 5.33M
Operating Expense	$ 5.29M	$ 6.16M	$ 7.17M	$ 11.27M	$ 10.49M	$ 10.28M
Operating Income	$ -567.00K	$ -1.92M	$ -2.82M	$ -5.73M	$ -3.47M	$ -4.94M
Net Non Operating Interest Income Expense	$ -143.00K	$ -128.00K	$ -113.00K	$ -77.00K	$ -48.00K	$ -59.00K
Other Income Expense	$ 5.00K	$ 1.15M	$ 207.00K	$ 1.54M	$ 1.39M	$ -1.07M
Pretax Income	$ -705.00K	$ -899.00K	$ -2.72M	$ -4.26M	$ -2.13M	$ -6.07M
Tax Provision	-	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -705.00K	$ -899.00K	$ -2.72M	$ -4.26M	$ -2.13M	$ -6.07M
Basic EPS	$ -0.04	$ -0.11	$ -0.36	$ -0.57	$ -0.33	$ -1.46
Diluted EPS	$ -0.04	$ -0.11	$ -0.36	$ -0.57	$ -0.33	$ -1.46
Basic Average Shares	$ 24.02M	$ 7.83M	$ 7.54M	$ 7.51M	$ 6.39M	$ 4.16M
Diluted Average Shares	$ 24.02M	$ 7.83M	$ 7.54M	$ 7.51M	$ 6.39M	$ 4.16M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 8.16M	$ 9.10M	$ 9.95M	$ 15.20M	$ 14.56M	$ 12.40M
Net Income From Continuing And Discontinued Operation	$ -705.00K	$ -899.00K	$ -2.72M	$ -4.26M	$ -2.13M	$ -6.07M
Normalized Income	$ -705.00K	$ -2.04M	$ -2.93M	$ -5.80M	$ -3.50M	$ -5.00M
Interest Expense	$ 143.00K	$ 128.00K	$ 113.00K	$ 77.00K	$ 48.00K	$ 59.00K
EBIT	$ -562.00K	$ -771.00K	$ -2.61M	$ -4.19M	$ -2.08M	$ -6.01M
EBITDA	$ -329.00K	$ -509.00K	$ -2.36M	$ -3.90M	$ -1.77M	$ -5.68M

Currency in USD

International Stem Cell Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing